Cite
HARVARD Citation
Poizot-Martin, I. et al. (2016). Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study. HIV clinical trials. 17 (2), pp. 63-71. [Online].